Synergistic Activation of the Human Type II 3beta-hydroxysteroid Dehydrogenase/delta5-delta4 Isomerase Promoter by the Transcription Factor Steroidogenic Factor-1/adrenal 4-binding Protein and Phorbol Ester
Overview
Authors
Affiliations
Steroidogenic factor-1/adrenal 4-binding protein (SF-1/Ad4BP) is an orphan nuclear receptor/transcription factor known to regulate the P450 steroid hydroxylases; however, mechanisms that regulate the activity of SF-1/Ad4BP are not well defined. In addition, little is known about the mechanisms that regulate the human steroidogenic enzyme, type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD II), the major gonadal and adrenal isoform. Regulation of the 3beta-HSD II promoter was examined using human adrenal cortical (H295R; steroidogenic) and cervical (HeLa; non-steroidogenic) carcinoma cells. H295R cells were transfected with a series of 5' deletions of 1251 base pairs (bp) of the 3beta-HSD II 5'-flanking region fused to a chloramphenicol acetyltransferase (CAT) reporter gene followed by treatment with or without phorbol ester (phorbol 12-myristate 13-acetate; PMA). CAT assay data indicated that the region from -101 to -52 bp of the promoter was required for PMA-induced expression. A putative SF-1/Ad4BP regulatory element, TCAAGGTAA, was identified by sequence homology at -64 to -56 bp of the promoter. Cotransfection of HeLa cells with the -101 3beta-HSD-CAT construct and an expression vector for SF-1/Ad4BP increased CAT activity 49-fold. Subsequent treatment with PMA induced an unexpected synergistic increase in transcriptional activity 540-fold over basal. Mutation of the putative response element (TCAAGGTAA to TCAATTTAA) abolished SF-1-induced CAT activity and the synergistic response to PMA. Gel mobility shift assays confirmed that SF-1/Ad4BP interacts with the putative element and transcripts for SF-1/Ad4BP were detected in H295R cells by Northern analysis. These data are the first to demonstrate 1) regulation of a non-cytochrome P450 steroidogenic enzyme promoter by SF-1/Ad4BP, 2) a powerful synergistic effect of PMA on SF-1/Ad4BP-induced transcription, and 3) the importance of the SF-1/Ad4BP regulatory element in the regulation of the 3beta-HSD II promoter.
Costagliola A, Montano L, Langella E, Lombardi R, Squillacioti C, Mirabella N Vet Sci. 2024; 11(3).
PMID: 38535865 PMC: 10975741. DOI: 10.3390/vetsci11030131.
Models of Congenital Adrenal Hyperplasia for Gene Therapies Testing.
Glazova O, Bastrich A, Deviatkin A, Onyanov N, Kaziakhmedova S, Shevkova L Int J Mol Sci. 2023; 24(6).
PMID: 36982440 PMC: 10049562. DOI: 10.3390/ijms24065365.
Expression and Transcript Localization of , and in the Early Brain of the Orange-Spotted Grouper .
Nagarajan G, Aruna A, Alkhamis Y, Mathew R, Chang C Int J Mol Sci. 2022; 23(5).
PMID: 35269757 PMC: 8910455. DOI: 10.3390/ijms23052614.
Pubertal development in 46,XY patients with NR5A1 mutations.
Monig I, Schneidewind J, Johannsen T, Juul A, Werner R, Lunstedt R Endocrine. 2021; 75(2):601-613.
PMID: 34613524 PMC: 8816419. DOI: 10.1007/s12020-021-02883-y.
Gene expression and functional abnormalities in XX/Sry Leydig cells.
Yanai S, Baba T, Inui K, Miyabayashi K, Han S, Inoue M Sci Rep. 2021; 11(1):719.
PMID: 33436964 PMC: 7804417. DOI: 10.1038/s41598-020-80741-z.